Invest-NL β 2026 Investments
3 investments dated 2026 Β· listed companies and verified rows first Β· show all
Axelera AI develops hardware and software platforms for artificial intelligence inference at the edge, including specialized processors and accelerators for edge computing, computer vision, natural language processing, and automotive applications.
AI & Machine LearningHardwareSemiconductors
Fabrizio Del MaffeoinEvangelos Eleftheriou(Founder)in
Co-investorsInnovation IndustriesSamsung Catalyst FundVerve VenturesBlackRockEuropean Innovation Council FundCDP Venture Capital+1 more
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission.
BiotechDeep TechHealthtechLeiden, NL
Koenraad Wiedhaup(Founder & Chief Executive Officer)inRonald Brus(Founder & Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)inDinko Valerio(Founder and Chair of the Supervisory Board)inJintanat Ananworanich(Chief Medical Officer)inClarissa Koch(Chief Scientific Officer)in
Co-investorsClavystBioF-Prime CapitalGV (Google Ventures)Bluebird VenturesCasdin CapitalEuropean Innovation Council Fund+5 more
Xeltis develops implantable vascular devices that transform into living tissue using Restorex supramolecular polymer technology.
BiotechDeep TechHealthtechMedical Devices
Eliane Schutte(Chief Executive Officer)in
Co-investorsKurma PartnersVI PartnersYsios CapitalEQT Life Sciences
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.